Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» nivolumab
nivolumab
Bicycle Therapeutics announces first patient dosed in phase I dose escalation of BT5528 in combination with nivolumab
Pharmaceutical Business Review
Wed, 05/6/20 - 12:10 pm
Bicycle Therapeutics
clinical trials
BT5528
nivolumab
Bristol immunotherapy shows promise in lung cancer trial
Yahoo/AP
Thu, 10/30/14 - 09:58 am
Bristol-Myers Squibb
non-small cell lung cancer
nivolumab
Most popular news headlines for Monday, August 4 2014
CP Wire
Mon, 08/4/14 - 11:20 pm
ebola virus
TKM-EBOLA
Bristol-Myers Squibb
GSK
Sanofi
Advair
nivolumab
FirstWord Lists: Pharma's biggest pipeline drugs
First Word Pharma
Mon, 08/4/14 - 11:53 am
pipelines
nivolumab
Pembrolizumab
evolocumab
palbociclib
cancer
breast cancer
Pfizer
Bristol-Myers Squibb
Merck
Amgen
Bristol-Myers Squibb May Be Fast-Tracking Its Promising Cancer Drug
Seeking Alpha
Fri, 07/4/14 - 11:45 am
Bristol-Myers Squibb
nivolumab
fast track
immuno-oncology
Pharma’s Huge Bet on Immunotherapies
Motley Fool
Wed, 06/25/14 - 07:35 am
immunotherapy
anti-PD-1 immunotherapy
anti-PD-L1
MK-3475
Merck
nivolumab
Roche
Bristol-Myers Squibb
Bristol-Myers says Phase 3 study of nivolumab versus dacarbazine stopped early
Yahoo/Fly on the Wall
Tue, 06/24/14 - 05:15 pm
nivolumab
Bristol-Myers Squibb
dacarbazine
melanoma
Bristol Shares Sag On Cancer Drug Worries
Forbes
Thu, 06/5/14 - 10:53 pm
Bristol-Myers Squibb
Yervoy
nivolumab
cancer
Bristol Defends Data; Roche Shines In Cancer Showdown
Investors.com
Mon, 06/2/14 - 02:51 pm
Roche
Bristol-Myers Squibb
nivolumab
Yervoy
melanoma
MPDL3280A
bladder cancer
ASCO
U.S. to test Bristol-Myers immunotherapy drugs on newly diagnosed brain tumors
Yahoo/Reuters
Mon, 06/2/14 - 09:42 am
Yervoy
brain cancer
immunotherapy
Bristol-Myers Squibb
ASCO
nivolumab
Bristol-Myers, Incyte enter collaboration agreement for nivolumab, INCB24360
The Fly on the Wall
Tue, 05/27/14 - 09:14 am
Bristol-Myers Squibb
Incyte
nivolumab
melanoma
non-small cell lung cancer
colorectal cancer
ovarian cancer
INCB24360
Bristol-Myers: Nivolumab Holds Good Potential
Seeking Alpha
Mon, 05/12/14 - 08:12 am
nivolumab
Bristol-Myers Squibb
6 Drugs That Could Move the Pharma Market
Wall St Cheat Sheet
Wed, 04/30/14 - 12:37 pm
Gilead Sciences
Teva Pharmaceuticals
Copaxone
Idelalisib
Bristol-Myers Squibb
nivolumab
Cyramza
Eli Lilly
Pfizer
palbociclib
Sovaldi
Bristol-Myers racing to the FDA with immunotherapy star nivolumab
Fierce Biotech
Tue, 04/29/14 - 10:05 am
FDA
immunotherapy
nivolumab
Bristol-Myers Squibb
Durable melanoma remission seen with Bristol immunotherapy drug
Yahoo/Reuters
Mon, 03/3/14 - 06:44 pm
Bristol-Myers Squibb
nivolumab
melanoma
metastatic melanoma
Bristol-Myers - Nivolumab's Delays Warrant Friday's Sell-Off
Seeking Alpha
Tue, 01/28/14 - 08:50 am
Bristol-Myers Squibb
nivolumab
AstraZeneca
Pace of Bristol-Myers' cancer trial spooks investors
Yahoo/Reuters
Sat, 01/25/14 - 11:14 am
Bristol-Myers Squibb
nivolumab
lung cancer
Bristol-Myers' New Nivolumab Trial Sparks Worries
Investors.com
Thu, 01/23/14 - 05:50 pm
Bristol-Myers Squibb
nivolumab
clinical trials
non-small cell lung cancer
Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race
Seeking Alpha
Thu, 01/2/14 - 09:35 am
Bristol-Myers Squibb
Roche
brain cancer
CytRx
Celldex Therapeutics
ImmunoCellular Therapeutics
Northwest Biotherapeutics
glioblastoma multiforme
nivolumab
Yervoy
Bristol-Myers Squibb Gains 6% on Promising Cancer Treatment, Upgrade
Barron's
Mon, 10/28/13 - 12:10 pm
Bristol-Myers Squibb
nivolumab
lung cancer
Pages
1
2
next ›
last »